Incivek Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Condition:   Hepatitis CInterventions:   Drug: Telaprevir;   Drug: ribavirin;   Drug: peginterferon alfa-2aSponsor:   Vertex Pharmaceuticals IncorporatedActive, not recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials

A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Condition:   Hepatitis CInterventions:   Drug: Telaprevir;   Drug: Ribavirin;   Biological: Pegylated Interferon Alfa-2a;   Drug: Highly Active Antiretroviral Therapy (HAART)Sponsor:   Vertex Pharmaceuticals IncorporatedTerminated - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials

An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Condition:   Hepatitis CInterventions:   Drug: Telaprevir;   Drug: ribavirin;   Drug: peginterferon alfa-2aSponsor:   Vertex Pharmaceuticals IncorporatedActive, not recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials